Why Scalp Cooling Technology Matters Beyond Chemotherapy
Scalp cooling caps were originally developed to prevent hair loss during chemotherapy by constricting blood vessels in the scalp, reducing the delivery of chemotherapy drugs to hair follicles. However, the technology has expanded beyond oncology to include cryotherapy and cold therapy devices marketed for general scalp health, circulation improvement, and hair growth support. Understanding the different categories of scalp cooling devices—and the evidence (or lack thereof) for each—is essential before investing in these more common products.
The FDA has cleared two scalp cooling systems specifically for chemotherapy-induced hair loss: DigniCap and Paxman. These are medical devices with published clinical evidence. The at-home cold therapy devices marketed for general hair care do not have the same level of evidence.
Medical Scalp Cooling for Chemotherapy
How It Works: During chemotherapy, a scalp cooling cap is worn before, during, and after infusion. The cold temperature (typically -30°C to -40°C / -22°F to -40°F) constricts blood vessels in the scalp, reducing blood flow and limiting the amount of chemotherapy drug that reaches hair follicles. Also, the cold may slow the metabolic rate of follicle cells, reducing their uptake of the chemotherapy drug.
DigniCap Delta: FDA-cleared for reducing hair loss during chemotherapy in patients with solid tumors. Uses a digitally controlled cooling system with a silicone cap that maintains consistent scalp temperature. The system circulates cooled liquid through the cap and is monitored by a control unit. Clinical study: A study by Nangia et al. (2017) published in JAMA found that 66% of patients using DigniCap retained 50% or more of their hair during chemotherapy, compared to 0% in the non-cooling control group. Available through participating cancer centers. Cost: approximately $1,500-3,000 per chemotherapy cycle (may be partially covered by some insurance plans).
Paxman Scalp Cooling System: FDA-cleared for the same indication. Uses a similar circulating liquid cooling system with a single-piece cap. Clinical study: A study by Rugo et al. (2017) published in the Journal of Clinical Oncology found that 50.5% of patients using Paxman scalp cooling retained 50% or more of their hair during chemotherapy with taxane-based regimens, compared to 0% in the control group. . Cost: similar to DigniCap at $1,500-3,000 per cycle.
Penguin Cold Caps: A manual system using frozen gel caps that must be stored in a special freezer and changed every 20-30 minutes during chemotherapy. The manual system requires a helper to manage cap changes during treatment. Less expensive than DigniCap or Paxman (approximately $400-600 per cycle for cap rental plus the cost of a -30°C freezer) but more labor-intensive. Not FDA-cleared (it is a manual system rather than a medical device), but widely used in clinical practice.
Cosmetic Cold Therapy Devices
A growing number of devices marketed for general scalp health use cold therapy at much milder temperatures than medical scalp cooling systems. These devices are designed for at-home use and claim benefits including improved circulation, reduced inflammation, and support for hair growth.
Cryo-Cap Pro (Cosmetic): $89. A gel-filled cap that is frozen in a standard home freezer (reaching approximately -18°C / 0°F—much warmer than the -30°C to -40°C used in medical devices). Worn for 15-20 minutes per session. The manufacturer claims improved scalp circulation through the cold-induced vasodilation that follows the initial vasoconstriction (a phenomenon called reactive hyperemia). There is no published clinical evidence for this specific product or its hair growth claims.
Ice Roller for Scalp: $12-25. A simple stainless steel roller that is frozen and then rolled over the scalp. Provides brief, localized cooling. The cold reduces inflammation and temporarily increases blood flow to the treated area after removal (reactive hyperemia). No clinical evidence for hair growth, but the anti-inflammatory effect is plausible based on the general principles of cryotherapy. Best for: reducing scalp inflammation and providing a soothing, refreshing sensation.
TheraICE Rx Scalp Cooling Cap: $29.99. A flexible gel cap that can be heated or cooled. When frozen, it provides approximately 15-20 minutes of cooling at a moderate temperature. Less intense than dedicated cryotherapy devices but more convenient for regular use. Best for: occasional cold therapy as part of a scalp care routine.
The Science of Cold Therapy and Hair Follicles
For Chemotherapy-Induced Hair Loss: The evidence is strong and FDA-cleared. Both the Nangia (2017) and Rugo (2017) studies demonstrated that medical-grade scalp cooling significantly reduces chemotherapy-induced hair loss, with 50-66% of patients retaining at least half their hair. The mechanism (vasoconstriction reducing drug delivery to follicles) is proven.
For General Hair Growth: The evidence is minimal. The proposed mechanism—cold-induced reactive hyperemia increasing blood flow to follicles after the cold is removed—is biologically plausible but has not been validated in clinical trials for hair growth. A study by Bickford (1953) in the Journal of Applied Physiology documented reactive hyperemia after cold exposure, but this was not studied in the context of hair follicles or hair growth. At the milder temperatures used in cosmetic devices (0°C to -18°C), the degree of vasoconstriction and subsequent reactive hyperemia is likely much less than in medical devices operating at -30°C to -40°C.
For Scalp Inflammation: Cold therapy is a proven anti-inflammatory modality. Reducing scalp inflammation may create a healthier environment for follicle function, but this has not been specifically studied in the context of androgenetic alopecia or other hair loss conditions.
Practical Recommendations
For chemotherapy patients: Discuss scalp cooling with your oncologist. DigniCap and Paxman are FDA-cleared with strong clinical evidence. Ask whether your treatment center offers these systems. Penguin Cold Caps are a more affordable manual alternative.
For general scalp health: An ice roller ($12-25) is an affordable way to experiment with cold therapy for scalp inflammation reduction. The anti-inflammatory effect is real, though the hair growth benefit is unproven. Use for 5-10 minutes, 2-3 times per week, rolling gently across the scalp.
For hair growth specifically: There is insufficient evidence to recommend cold therapy devices as a primary or standalone treatment for hair growth. Invest in proven treatments (minoxidil, finasteride) first, and consider cold therapy as a complementary approach for scalp inflammation if desired.
Frequently Asked Questions
Q: Can I use a frozen gel cap from Amazon for hair growth?
A: You can try it, but there is no clinical evidence that cosmetic-grade cold therapy promotes hair growth. The temperatures are much milder than medical devices, and the hair growth benefit has not been validated in clinical trials. The anti-inflammatory effect may support scalp health, which is a reasonable but indirect benefit.
Q: Is scalp cooling safe?
A: When used as directed, yes. Avoid applying ice directly to the scalp (always use a barrier like a cap or cloth), limit sessions to 15-20 minutes, and do not use on broken or infected skin. People with cold sensitivity (Raynaud’s phenomenon) should avoid scalp cooling devices.
Q: Does insurance cover medical scalp cooling for chemotherapy?
A> Coverage varies by insurance plan and state. As of 2024, 14 US states mandate insurance coverage for scalp cooling during chemotherapy. Check with your insurance provider and treatment center for specific coverage information.
The History and Evolution of Scalp Cooling Technology
Scalp cooling for chemotherapy-induced hair loss was first reported in the 1970s, when Dutch oncologists noticed that patients who used ice packs on their heads during chemotherapy experienced less hair loss. The first dedicated scalp cooling device (the Penguin Cold Cap system) was developed in the Netherlands in the 1990s and used manually changed frozen gel caps. The major advancement came in the 2000s with the development of machine-cooled systems (DigniCap and Paxman) that maintained consistent temperatures without manual cap changes, significantly improving convenience and efficacy.
The expansion of scalp cooling from chemotherapy to cosmetic applications is a more recent trend, driven by the growing interest in cryotherapy and cold therapy for general wellness. While the medical evidence for scalp cooling during chemotherapy is strong and FDA-cleared, the evidence for cosmetic cold therapy devices for general hair health is minimal. The fundamental difference is in temperature and mechanism: medical devices operate at -30°C to -40°C to achieve significant vasoconstriction and reduced drug delivery, while cosmetic devices operate at 0°C to -18°C—temperatures sufficient for anti-inflammatory effects but unlikely to produce the degree of vasoconstriction needed for meaningful hair growth benefits. Consumers should be aware of this distinction and manage expectations accordingly.
what matters most
For chemotherapy patients, medical scalp cooling systems (DigniCap and Paxman) are FDA-cleared with strong clinical evidence showing that 50-66% of patients retain at least half their hair during treatment. For general hair care, cold therapy devices lack clinical evidence for hair growth promotion. An ice roller ($12-25) provides an affordable, low-risk way to experiment with cold therapy for scalp inflammation reduction, but it should not be relied upon as a hair growth treatment. Invest in proven therapies first, and consider cold therapy as a supplementary scalp health practice if you find it soothing and beneficial for inflammation.